Apr 2 2010
NewLink Genetics Corporation announced that it has taken occupancy of its new administrative and manufacturing facility. The building includes both a cGMP manufacturing suite as well as administrative and executive offices. It is located on the campus of the Iowa State University Research Park in Ames, Iowa.
"NewLink should be able to supply all of its clinical drug supply and initial commercial supply requirements for its lead pancreatic cancer therapy from this facility," said Dr. Charles Link, Chairman and Chief Executive Officer of NewLink Genetics Corporation. "In addition, we plan to eventually move all of our pilot manufacturing for a new series of HyperAcute cancer immunotherapies to this facility as well."
SOURCE NewLink Genetics Corporation